Exchange: OTC Sector: Healthcare Industry: Biotechnology
0.00% $0.600
America/New_York / 1 mai 2024 @ 10:50
FUNDAMENTALS | |
---|---|
MarketCap: | 4.35 mill |
EPS: | -0.140 |
P/E: | -4.29 |
Earnings Date: | May 12, 2024 |
SharesOutstanding: | 7.24 mill |
Avg Daily Volume: | 0.0005 mill |
RATING 2024-05-01 |
---|
C |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Sell | |
Return On Equity: | Strong Buy | |
Return On Asset: | Strong Sell | |
DE: | Strong Sell | |
P/E: | Sell | |
Price To Book: | Strong Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | ||||||
Asset | ||||||
Debt |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -4.29 | sector: PE 29.05 |
PE RATIO: COMPANY / INDUSTRY |
---|
-0.03x |
Company: PE -4.29 | industry: PE 136.10 |
DISCOUNTED CASH FLOW VALUE |
---|
$-0.139 (-123.21%) $-0.739 |
Date: 2024-05-06 |
Expected Trading Range (DAY) |
---|
$ 0.532 - 0.668 ( +/- 11.33%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2022-02-18 | King Steven W | Buy | 0 | Convertible Note |
2022-02-18 | Felcyn Gloria | Buy | 0 | Convertible Note |
2022-02-18 | Garnick Robert L | Buy | 0 | Convertible Note |
2022-02-18 | Baffi Robert | Buy | 0 | Convertible Note |
2022-02-18 | Steinmetz Nicole Franziska | Buy | 0 | Convertible Note |
INSIDER POWER |
---|
-100.00 |
Last 97 transactions |
Buy: 15 573 389 | Sell: 402 731 447 |